Derivatives of thiocolchicine and its applications to CEM cells treatment using 19F Magnetic Resonance ex vivo

Download
  1. (PDF, 396 KB)
  2. Get@NRC: Derivatives of thiocolchicine and its applications to CEM cells treatment using 19F Magnetic Resonance ex vivo (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1016/j.bioorg.2009.10.002
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleBioorganic Chemistry
Volume38
Issue1
Pages16; # of pages: 6
SubjectThiocolchicine; Human T-Lymphoblastoid; Three-dimensional cell culture; Magnetic Resonance Imaging; High Performance Liquid Chromatography coupled with Ultra Violet
AbstractIt was shown, that cultured ex vivo human T-Lymphoblastoid (CEM) cells respond to synthesized thiocolchicine and fluorine thiocolchicine derivatives. The preparation of derivatives with substitution at C-3 and C-7 is described. All compounds were used at concentration from 1 nM to 1000 nM. Inhibitory effects of these compounds were examined in the three-dimensional (3-D) culture and cells morphology during treatment was monitored using 9.4 T MRI system. We performed studies of these compounds in CEM cells ex vivo using 1H and 19F Magnetic Resonance Imaging (MRI), 19F Magnetic Resonance Spectroscopy (MRS), High Performance Liquid Chromatography coupled with Ultra Violet (HPLC-UV) and Electron Impact Mass Spectrometry (EIMS). The results of the multi-technique approach are consistent with the fact that the new derivatives are more efficient than colchicine and thiocolchicine ex vivo.
Publication date
LanguageEnglish
AffiliationNRC Institute for Biodiagnostics; National Research Council Canada
Peer reviewedYes
NPARC number17653081
Export citationExport as RIS
Report a correctionReport a correction
Record identifier9601f55c-c537-459c-bc67-6ee170a072bf
Record created2011-04-03
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)